CE vs CRON · rev $10.28B vs P/E 14, rev $117.6M
Celanese Corporation (CE) versus Cronos Group Inc (CRON) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CRON revenue for 2024-12-31 was $117.6M. Net income was $40.0M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
CE currently screens at market cap $5.92B. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
Not investment advice. Open the CE and CRON stock pages for the full models.
Not investment advice.